In this video Professor Campisi talks her personal protocol for staying healthy and some of the research that her lab is now working on. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and thei...
Dec 29, 2021•11 min•Season 8Ep. 8
In this video Professor Campisi talks her personal protocol for staying healthy and some of the research that her lab is now working on. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and thei...
Dec 26, 2021•7 min•Season 8Ep. 7
In this video Professor Campisi talks about what lifestyle habits can minimize the senescent cells in our body. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and their influence on many manif...
Dec 22, 2021•7 min•Season 8Ep. 6
In this video Professor Campisi talks about why detecting senescent cells is difficult and the biomarker that her team recently found that shows how effective a senolytic is and can also be used to determine the level of senescent burden. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical c...
Dec 19, 2021•6 min•Season 8Ep. 5
In this video Professor Campisi talks about how senescent cells are heterogeneous and their interaction with the immune system which leads to inflammaging. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senes...
Dec 14, 2021•7 min•Season 8Ep. 4
In this video Professor Campisi talks about how senescent cells are heterogeneous and their interaction with the immune system which leads to inflammaging. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senes...
Dec 12, 2021•8 min•Season 8Ep. 3
In this video Professor Campisi talks why we have senescent cells, a possible schedule for taking senolytics, and senescent cells and cancer. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and...
Dec 08, 2021•10 min•Season 8Ep. 2
In this video Professor Campisi talks about what led her to study aging. She also covers her ideas on why we age and how senescent cells fit into that. The Campisi lab at the Buck Institute https://www.buckinstitute.org/lab/campisi-lab/ Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent...
Dec 05, 2021•13 min•Season 8Ep. 1
In this video Professor Church talks about his work on his project to recreate a mammoth in the Siberian Arctic. He also talks about the latest work that his lab is working on. George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and MIT. Professor Church helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. He is widely recognized for his innovative contributions to geno...
Dec 02, 2021•10 min•Season 7Ep. 6
In this video Professor Church talks about why everyone should get their complete genome sequenced and how we genetic engineering has created organisms which are immune to all viruses, and how potentially this technology could be used for humans. Nebula Genomics - full genome sequencing company started by Professor Church. https://nebula.org/whole-genome-sequencing-dna-test/ George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and T...
Nov 28, 2021•11 min•Season 7Ep. 5
In this video Professor Church talks about the latest updates in xenotransplantation technology and how they are getting close to clinical trials with the latest Pig 3.0 that has been built with the gene technologies from his lab. He also talks about universal chimeric antigen receptors (CAR) T-Cells for stem cell transplantation. George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and MIT. Professor Churc...
Nov 24, 2021•10 min•Season 7Ep. 4
In this video Professor Church talks about the latest techniques for building AAVs and using them to delivery gene therapies. George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and MIT. Professor Church helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. He is widely recognized for his innovative contributions to genomic science and his many pioneering contributions t...
Nov 21, 2021•12 min•Season 7Ep. 3
In this video Professor Church talks how he is using gene therapy to target aging and the benefits of gene therapy when compared to using small molecules. He talks about the study where his lab used a small number of gene therapies to target five or more diseases of aging and the follow up they are now doing. George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and MIT. Professor Church helped initiate the ...
Nov 10, 2021•12 min•Season 7Ep. 2
In this video Professor Church talks about his theory of aging and touches on his ideas on the future of aging. George Church is the Robert Winthrop Professor of Genetics at Harvard Medical School, a Professor of Health Sciences and Technology at Harvard and MIT. Professor Church helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. He is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry an...
Nov 07, 2021•10 min•Season 7Ep. 1
In Episode 6 Dr. Lithgow talks about the latest research that he is doing in his lab, what his personal longevity protocol is as well how we can move forward with making interventions available for aging. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a Glenn Award for Research in ...
Oct 27, 2021•17 min•Season 4Ep. 6
In Episode 5 Dr. Lithgow talks about the different forms of AKG and why they chose to go with CaAKG. He also touches on the difficulty in doing the kind of head to head studies that would be able to see if either was more effective. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a ...
Oct 24, 2021•10 min•Season 4Ep. 5
In Episode 4 Dr. Lithgow talks about , some other potential benefits of AKG rather than extend healthspan and lifespan. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a Glenn Award for Research in Biological Mechanisms of Aging and the Tenovus Award for Biomedical Research. *******...
Oct 17, 2021•8 min•Season 4Ep. 4
In Episode 3 Dr. Lithgow introduces AKG, or Alpha Ketoglutarate and talks about a recent trial that they did with mice. In the trial they saw both increased lifespan and healthspan, mostly in the female mice. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a Glenn Award for Research...
Oct 11, 2021•16 min•Season 4Ep. 3
In the talk Dr. Lithgow discusses the current drugs that are available along with some of the limitations of the studies that we are currently doing. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a Glenn Award for Research in Biological Mechanisms of Aging and the Tenovus Award fo...
Sep 12, 2021•6 min•Season 4Ep. 2
In Episode 1 Dr. Lithgow talks about his journey to study aging, his thoughts on why we age and whether there is limit to the age that humans can live to. Dr. Gordon Lithgow, is a professor and vice president of Academic Affairs at the Buck Institute. Dr. Lithgow's research focuses on uncovering genes and small molecules that prolong lifespan through enhanced molecular stability. Dr. Lithgow has been recognized with a Glenn Award for Research in Biological Mechanisms of Aging and the Tenovus Awa...
Aug 15, 2021•11 min•Season 6Ep. 1
In this video Dr. Sabatini discusses some of the life style interventions that affect our longevity and his personal regimen. This is the last episode of Dr. Sabatani Interview Series. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of m...
Aug 09, 2021•10 min•Season 4Ep. 6
Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabatini has continued to work on better understanding this complex regulator of our metabolism In this video Dr. Sabatini discusses how diet...
Aug 01, 2021•15 min•Season 4Ep. 5
In this video Dr. Sabatini discusses rapamycin, how it acts on mTORC1 and mTORC2 and the rapalogs, drugs which are similar to rapamycin but may be more clinically effective. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more t...
Jul 11, 2021•9 min•Season 4Ep. 4
In this video Dr. Sabatini discusses his recent paper and in particular how the health of the mitochondria impact the activation of mTOR and how this is signaled. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 year...
Jul 04, 2021•7 min•Season 4Ep. 3
Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabatini has continued to work on better understanding this complex regulator of our metabolism In this video Dr. Sabatini discusses how mTOR...
Jun 28, 2021•9 min•Season 4Ep. 2
In this video Dr. Sabatini discusses the role of mTOR as the master regulator of the cell and distinguishes between mTORC1 and mTORC2. Dr. David Sabatini is an American scientist and Professor of Biology at the Massachusetts Institute of Technology as well as a member of the Whitehead Institute for Biomedical Research. He is known for his important contributions in the areas of cell signaling and cancer metabolism, most notably the discovery of mTOR, more than 20 years ago. Since then Dr. Sabati...
Jun 13, 2021•11 min•Season 4Ep. 1
In this video talks about the biological age measurement in his research study and also his views on Exercise as an important contributor for extending healthspan. We also look at a paper by his team which looks in depth at the effects of acute exercise on the biochemistry of the body. https://www.sciencedirect.com/science/article/abs/pii/S0092867420305080 Dr. Snyder is the Stanford W. Ascherman Professor and Chair, Department of Genetics and Director, Center for Genomics and Personalized Medici...
May 26, 2021•10 min•Season 4Ep. 6
Dr. Snyder is the Stanford W. Ascherman Professor and Chair, Department of Genetics and Director, Center for Genomics and Personalized Medicine at Stanford University. He is a leader in the field of functional genomics and proteomics. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and wit...
May 22, 2021•12 min•Season 5Ep. 5
Dr. Snyder is the Stanford W. Ascherman Professor and Chair, Department of Genetics and Director, Center for Genomics and Personalized Medicine at Stanford University. He is a leader in the field of functional genomics and proteomics. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and wit...
May 16, 2021•7 min•Season 4Ep. 4
Dr. Snyder is the Stanford W. Ascherman Professor and Chair, Department of Genetics and Director, Center for Genomics and Personalized Medicine at Stanford University. He is a leader in the field of functional genomics and proteomics. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and wit...
May 03, 2021•18 min•Season 4Ep. 3
